Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BILe Duct and LIver Cancer: ON-treatment Surveillance of Tumor Evolution And Response to Systemic Treatment

NCT06877637 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT06877637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BILe Duct and LIver Cancer: ON-treatment Surveillance of Tumor Evolution And Response to Systemic Treatment
Lead sponsor
Region Skane
Phase
Observational
Overall status
Recruiting
Start date
May 15, 2025
Completion date
December 31, 2029
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, hepatocellular carcinoma (hcc)